Renal Outcome of Neonatal Renal Venous Thrombosis: Review of 28 Patients and Effectiveness of Fibrinolytics and Heparin in 10 Patients

OBJECTIVES. Neonatal renal venous thrombosis is a rare disorder that can result in severe renal damage. To evaluate the experience over 10 years and review the effectiveness of fibrinolytic and/or heparin therapy, chart reviews were performed for newborns with renal venous thrombosis. PATIENTS, INTERVENTIONS, AND OUTCOME MEASURES. Twenty-eight newborns with renal venous thrombosis were treated at Children's Hospitals and Clinics of Minnesota and Fairview University Medical Center from 1991 to 2001. RESULTS. Unilateral involvement was noted in 25 neonates (89%) and bilateral involvement in 3 (11%). Unilateral renal venous thrombosis affected mostly term infants, whereas 2 of 3 infants with bilateral renal venous thrombosis were <32 weeks' gestational age (birth weight: 745–1505 g). One mother had antiphospholipid syndrome. Of 11 neonates evaluated for congenital thrombophilia, 1 had the factor V Leiden mutation. Ten neonates received either unfractionated or low molecular weight heparin for 3 days to 7 months. Three infants with unilateral renal venous thrombosis treated with heparin alone did not seem to benefit from such therapy. Seven neonates were treated with fibrinolytics and unfractionated heparin (4 neonates with unilateral renal venous thrombosis and 3 with bilateral renal venous thrombosis). Treatment with fibrinolytics did not result in restoration of renal function in the 4 neonates with unilateral renal venous thrombosis but was associated with return of almost normal function in the 2 neonates with bilateral renal venous thrombosis who received fibrinolytics immediately after renal venous thrombosis diagnosis. Two neonates treated with fibrinolytics suffered bleeding complications at the area of adrenal hemorrhage. Two neonates (not treated for renal venous thrombosis) died as a result of underlying disease. CONCLUSIONS. Most neonatal renal venous thrombosis is unilateral and does not respond to fibrinolytic therapy and heparin. The use of fibrinolytics may prevent chronic renal failure in neonates with bilateral renal venous thrombosis if begun within 24 hours of diagnosis. Fibrinolytic therapy, however, is associated with a risk of bleeding, specifically if there is an associated adrenal hemorrhage.

[1]  Salwa Khan,et al.  Hereditary thrombophilia , 2006, Thrombosis journal.

[2]  L. Wadsworth,et al.  Renal vein thrombosis and response to therapy in a newborn due to protein C deficiency , 1989, European Journal of Pediatrics.

[3]  P. Monagle,et al.  Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[4]  K. Kurnik,et al.  Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. , 2004, Blood.

[5]  S. Kuhle,et al.  A case series of 72 neonates with renal vein thrombosis , 2004, Thrombosis and Haemostasis.

[6]  M. Andrew,et al.  Hemostatic complications in renal disorders of the young , 1996, Pediatric Nephrology.

[7]  H. Mocan,et al.  Renal venous thrombosis in infancy: Long-term follow-up , 2004, Pediatric Nephrology.

[8]  J. Fiascone,et al.  Combination thrombolytic and anticoagulant therapy for bilateral renal vein thrombosis in a premature infant. , 2001, American journal of perinatology.

[9]  R. Junker,et al.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. , 2000 .

[10]  R. Junker,et al.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study , 2000, British journal of haematology.

[11]  S. Emil,et al.  Renal vein thrombosis: a 10-year review. , 2000, Journal of pediatric surgery.

[12]  L. Drouet,et al.  Multiplex PCR-mediated Site-directed Mutagenesis for One-step Determination of Factor V Leiden and G20210A Transition of the Prothrombin Gene , 1997, Thrombosis and Haemostasis.

[13]  A. Berghold,et al.  Intracerebral Hemorrhage During Fibrinolytic Therapy in Children: A Review of the Literature of the Last Thirty Years , 1997, Seminars in thrombosis and hemostasis.

[14]  J. Boos,et al.  Changes in coagulation and fibrinolysis in childhood ALL: a two‐step dose reduction of one E. coli asparaginase preparation , 1996, British Journal of Haematology.

[15]  J. Bowie,et al.  Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report , 1994, Prenatal diagnosis.

[16]  M. Manco-Johnson,et al.  Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. , 1994, The American journal of pediatric hematology/oncology.

[17]  C. Loirat,et al.  [Treatment of renal vein thromboses in the newborn]. , 1993, Annales de pediatrie.

[18]  C. Edelmann Pediatric Kidney Disease , 1992 .

[19]  R. M. Nelson,et al.  In utero arterial embolism from renal vein thrombosis with successful postnatal thrombolytic therapy. , 1991, Journal of pediatric surgery.

[20]  M. Ricci,et al.  Renal venous thrombosis in infants and children. , 1990, Archives of surgery.

[21]  J. Jobin,et al.  Neonatal renal vein thrombosis - long-term follow-up after conservative management. , 1982, Clinical nephrology.

[22]  G. Arneil Renal venous thrombosis. , 1979, Contributions to nephrology.

[23]  L. Martin,et al.  Natural history and treatment of renal vein thrombosis in children. , 1977, Journal of pediatric surgery.

[24]  Arneil Gc,et al.  Renal venous thrombosis. , 1973 .